Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Plenary Session 1: Latest Advances to Overcome Resistance to Targeted Therapies

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Using synthetic lethality to find effective combination therapies for cancer
René Bernards
Netherlands Cancer Inst., Amsterdam, Netherlands
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 10:30 AM-12:30 PM
Mechanisms of resistance to RAF/MEK inhibitors
David B. Solit
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 10:30 AM-12:30 PM
Overcoming acquired resistance to first-generation kinase inhibitors in lung cancer
William Pao
Vanderbilt Univ., Nashville, TN, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 10:30 AM-12:30 PM
Mechanisms of acquired resistance to ALK/ROS1 inhibitors
Alice T. Shaw
Massachusetts General Hosp. Cancer Ctr., Boston, MA, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 20, 2013 10:30 AM-12:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4